Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.725 USD | +1.93% | +0.57% | +79.27% |
May. 14 | Acrivon Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 30 | North American Morning Briefing : More Earnings -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+79.27% | 264M | |
+34.33% | 50.85B | |
+0.73% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+10.95% | 26.11B | |
-21.65% | 19.13B | |
+9.40% | 13.05B | |
+27.09% | 12.16B | |
+24.06% | 12.08B |
- Stock Market
- Equities
- ACRV Stock
- News Acrivon Therapeutics, Inc.
- Ladenburg Thalmann Cuts Price Target on Acrivon Therapeutics to $14 From $18, Maintains Buy Rating